SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

After a significant dip attributed to broader AI sector concerns and potential overreactions to $ORCL news, $CRWV is seeing active debate about its oversold condition and potential for a rebound. The community is closely watching for a recovery, fueled by its strong backlog and Nvidia's involvement, while also considering factors like insider selling and convertible debt. Discussions range from potential short squeezes to long-term bullish perspectives on AI infrastructure.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the company tests driverless cars in Austin, leading to speculation about full autonomy and future robotaxi services. The community is actively discussing the implications of this technology and potential impact on Tesla's valuation, with some pointing to high P/E ratios. Bullish sentiment is fueled by the possibility of new highs and a 'Santa Claus rally,' while bears express concerns about overvaluation and market manipulation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as traders assess its recent price drop amid concerns about AI infrastructure spending and potential rate hikes. Community discussions range from short-term bearish sentiment and technical analysis to long-term bullish outlooks based on the company's fundamentals and contracted revenue. Investors are weighing the impact of potential AI bubble concerns against IREN's growth prospects and existing deals.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

RKLB is trending due to a mix of factors including a recently aborted launch, planned share sales by Peter Beck, and broader tech sector volatility, leading to community discussion about short-term turbulence versus long-term potential. Despite these headwinds, many investors express confidence in the company's fundamentals and future growth, particularly related to the Neutron rocket and potential government contracts. The stock's movement is also influenced by speculation around a potential SpaceX IPO and its impact on the space sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals ($CRML) is trending amid discussions about rare earth element (REE) needs for military applications and reactions to recent drilling results from the Tanbreez Rare Earth Project. Community members are weighing the significance of these results and pondering the potential for future growth. Some are speculating on the impact of potential government investment and partnerships, while others express skepticism about the company's progress and the overall market's valuation of REE assets.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its explosive move and after-hours continuation, with community members actively discussing potential price targets and the possibility of a short squeeze. The stock, a robotics de-SPAC, is garnering attention despite sector challenges, with some drawing parallels to previous high-flying stocks and anticipating further gains. Traders are closely monitoring key resistance levels and potential breakout points.

$WORKIE is the official workers memecoin on Base.

Workie

Workie crypto is trending with increased community interest, indicated by repetitive mentions of the ticker. Speculation is building around potential catalysts for the token. The community appears to be coalescing around a bullish outlook.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to significant intraday volatility following positive Phase 2b trial data, leading to discussions about potential short squeezes and the company's financial stability. Community chatter revolves around high trading volume, potential price targets, and whether the stock is overvalued or poised for further gains based on its therapeutic pipeline. The stock's webinar presentation is also a key point of discussion, with investors looking for further catalysts.

Mask Network is the core product of Dimension, which is positioned to become the bridge that connects internet users from Web 2.0 to Web 3.0. The foundational technology of Mask Network is a peer-to-peer encrypted messaging application, with new functions continuously being created around this foundation. We at Mask Network are strong believers in the ownership economy. People should own what they produce, people should own their data, their attention and the virtual space they choose to contribute to.  Mask Network integrates decentralized social messaging, borderless payment network, and decentralized file storage and sharing to provide a safe and convenient portal for users to jump right into the continent of decentralized finance and then the new world of Web 3.0.

Mask Network

MASK is trending as community members discuss its potential as an AI stock, drawing comparisons to previous runners. Positive news and a low float are contributing to the bullish sentiment, with some anticipating a continued uptrend. Chatter revolves around potential price targets, but is mostly very speculative.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending as investors anticipate topline results from its Phase 2b study of Rezpegaldesleukin for alopecia areata, expected soon. The community is highly focused on the upcoming data, with some speculating on the potential impact on the stock price based on different outcomes. Discussions also include potential settlement outcomes from their lawsuit with Eli Lilly, adding another layer of speculation to the stock's movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agilent Technologies, Inc. (<a class="mention" data-mention="$A" data-symbol-id="A" href="https://stocktwits.com/symbol/A" target="_blank">$A</a>), a provider of analytical and clinical laboratory technologies, is due to report its fiscal year 2024 fourth-quarter results after the market closes on Monday, and the company is widely expected to report modest declines in both the top- and bottom-line.Analysts, on average, expect Santa Clara, California-based Agilent to report non-GAAP earnings per share (EPS) of $1.32, lower than the year-ago’s $1.38. The consensus calls for a decline in revenue from $169 billion to $1.67 billion.&nbsp;In late-August, the company’s guided to non-GAAP EPS of $1.38-$1.42 and revenue of $1.64 billion to $1.69 billion.Agilent, which was splintered from Hewlett-Packard Co. ($HPQ) in 1999, provides full-range of solutions including instruments, software, services and expertise. It caters to six key markets, namely food, pharmaceuticals, chemical &amp; advanced materials, environmental &amp; forensics, diagnostics and research.Last week, the company announced a 5% increase in its quarterly cash dividend to $0.248. The dividend would be paid on Jan. 22, 2025 to shareholders of record as of the close of business on Dec. 31, 2024.During the quarter, Agilent completed the acquisition of Canadian contract development and manufacturing organization Biovectra. It also announced Mito-rOCR Assay kit, an end-to-end solution that makes&nbsp;sophisticated analysis of mitochondrial function available to researchers of all skill levels.Agilent’s updated full-year guidance issued in August model non-GAAP EPS of $5.21-$5.25 and revenue of $6.45 billion-$6.50 billion.&nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/A"><img style="aspect-ratio:635/127;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/a_sentiment_76485e9d20.png" alt="a-sentiment.png" width="635" height="127"></a><figcaption>A sentiment and message volume November 24, 2024, as of 10:47 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>Users of the Stocktwits platform are largely 'bearish' (40/100) on Agilent stock, while message volume remained 'normal.'Agilent’s shares have declined 3.25% for the year-to-date period. The shares ended Friday’s session up 1.35% at $133.84.In mid-October, Barclays analyst Luke Sergott upped the price target for the stock from $135 to $145, while maintaining an 'Underweight' rating,&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://thefly.com/news.php?symbol=A">according</a> to the Fly.For updates and corrections email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bath-and-body-works-analyst-cautious-ahead-of-q3-print-retail-sentiment-deflates/cJIfbuGRg7">Bath &amp; Body Works Analyst Cautious Ahead Of Q3 Print: Retail Sentiment Deflates</a>

Agilent recently announced a 5% hike to its quarterly dividend: 

Agilent To Report Q4 Results Monday: Retail Sentiment Downbeat

Agilent’s shares have declined 3.25% for the year-to-date period, underperforming the broader market.

Equity

Agilent’s shares have declined 3.25% for the year-to-date period, underperforming the broader market.


VFQY
Vanguard Group, Inc. - Vanguard U.S. Quality Factor ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VFQY News

VFQYVanguard Group, Inc. - Vanguard U.S. Quality Factor ETF